ALDOA and Crohn disease: The addition of FANA-PGK1 or FANA-ALDOA reduced the frequency of RORC+ cells within CD4 lymphocytes obtained from patients with Crohn’s disease, this decrease trending towards significance (Supplementary Fig. 9a).